Display options
Share it on

Expert Rev Respir Med. 2016 Nov;10(11):1211-1220. doi: 10.1080/17476348.2016.1240037. Epub 2016 Oct 06.

Clinical management of community acquired pneumonia in the elderly patient.

Expert review of respiratory medicine

Catia Cilloniz, Adrian Ceccato, Alicia San Jose, Antoni Torres

Affiliations

  1. a Department of Pneumology , Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB) - SGR 911- Ciber de Enfermedades Respiratorias (Ciberes) , Barcelona , Spain.
  2. b Seccion Neumología , Hospital Nacional Alejandro Posadas, Palomar , Buenos Aires , Argentina.

PMID: 27690702 DOI: 10.1080/17476348.2016.1240037

Abstract

INTRODUCTION: Community acquired pneumonia (CAP) is a major health problem in elderly persons and is associated with high morbidity and mortality. Areas covered: This article reviews the most recent publications relative to CAP in the elderly population, with a focus on epidemiology, prognostic factors, microbial etiology, therapy and prevention. The data discussed in this review were mainly obtained from a non-systematic review using Medline, and references from relevant articles. Expert commentary: CAP can occur at any age, but its incidence and risk of death are linked to increasing age. Age-related changes in the immune system make this population more vulnerable to CAP. Mortality in hospitalized patients with CAP ranges from 10% to 12%. However, in the case of elderly patients, several studies have reported mortality rates of up to 25%. Pneumococcal and influenza vaccination comprise one of the most important preventive approaches for CAP in the elderly.

Keywords: Community-acquired pneumonia; elderly; pneumonia

Publication Types